Form 4: Amgen SVP Rachna Khosla Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Rachna Khosla, SVP of Business Development at Amgen, disposed of 41 shares of common stock on May 5, 2024, to satisfy tax obligations related to vested restricted stock units.
Summary
- On May 5, 2024, Rachna Khosla, Senior Vice President of Business Development at Amgen Inc., disposed of 41 shares of Amgen's common stock.
- The transaction was executed at a price of $311.29 per share.
- The disposal was related to covering tax obligations associated with vested Restricted Stock Units (RSUs).
- Following the transaction, Khosla directly owns 8,027 shares of Amgen common stock, which includes unvested RSUs and dividend equivalents.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction appears to be a standard tax-related stock disposal, common among executives with equity compensation.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine stock disposal for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 05/05/2024 | Date of stock disposal transaction. |
| 05/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.